Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$332M |
| 2 |
ExxonMobil
XOM
|
+$283M |
| 3 |
Verizon
VZ
|
+$165M |
| 4 |
Yum China
YUMC
|
+$137M |
| 5 |
Chevron
CVX
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$862M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$427M |
| 4 |
Dimensional International Small Cap Value ETF
DISV
|
+$421M |
| 5 |
Apple
AAPL
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.25% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Black Diamond Therapeutics
BDTX
$99.1M
| $101K | ﹤0.01% |
+60,046
| New | +$185K |
|
3327
Comstock Holding Companies
CHCI
$155M
| $101K | ﹤0.01% |
25,592
| – | – |
|
|
ITRM
3328
DELISTED
Iterum Therapeutics
ITRM
| $101K | ﹤0.01% |
+62,301
| New | +$189K |
|
3329
X4 Pharmaceuticals
XFOR
$372M
| $101K | ﹤0.01% |
1,977
-70
| -3% | -$2.42K |
|
|
APRN
3330
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $101K | ﹤0.01% |
1,452
| – | – |
|
|
SRGA
3331
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $101K | ﹤0.01% |
29,240
-439
| -1% | -$1.68K |
|
3332
KORU Medical Systems
KRMD
$187M
| $100K | ﹤0.01% |
44,661
+16,454
| +58% | +$40.7K |
|
3333
MediciNova
MNOV
$65M
| $100K | ﹤0.01% |
46,099
-2,575
| -5% | -$5.96K |
|
|
AKUS
3334
DELISTED
Akouos Inc
AKUS
| $100K | ﹤0.01% |
14,766
-1,061
| -7% | -$3.97K |
|
3335
Neonode
NEON
$12.9M
| $99K | ﹤0.01% |
28,402
+15,553
| +121% | +$66.7K |
|
3336
GrowGeneration
GRWG
$88.9M
| $98K | ﹤0.01% |
+28,107
| New | +$130K |
|
|
HYFT
3337
MindWalk Holdings
HYFT
$67.3M
| $98K | ﹤0.01% |
24,573
+9,209
| +60% | +$43.6K |
|
3338
Prelude Therapeutics
PRLD
$310M
| $97K | ﹤0.01% |
+14,616
| New | +$98.5K |
|
|
BRFS
3339
DELISTED
BRF SA
BRFS
| $96K | ﹤0.01% |
41,062
+2,258
| +6% | +$6.68K |
|
3340
QuickLogic
QUIK
$228M
| $96K | ﹤0.01% |
14,860
| – | – |
|
3341
Uranium Energy
UEC
$4.9B
| $96K | ﹤0.01% |
27,496
-59,924
| -69% | -$229K |
|
3342
Immunic
IMUX
$188M
| $95K | ﹤0.01% |
2,997
-1,369
| -31% | -$57.3K |
|
3343
Lightpath Technologies
LPTH
$686M
| $95K | ﹤0.01% |
88,863
-43,000
| -33% | -$63.7K |
|
|
NINE
3344
DELISTED
Nine Energy Service
NINE
| $95K | ﹤0.01% |
+36,115
| New | +$102K |
|
3345
CPS Technologies
CPSH
$76.7M
| $94K | ﹤0.01% |
33,583
+7,031
| +26% | +$23.8K |
|
3346
ThredUp
TDUP
$756M
| $94K | ﹤0.01% |
+51,246
| New | +$129K |
|
|
LGO
3347
Largo
LGO
$62.2M
| $93K | ﹤0.01% |
17,572
| – | – |
|
3348
Larimar Therapeutics
LRMR
$398M
| $93K | ﹤0.01% |
29,212
+4,474
| +18% | +$11.2K |
|
3349
Praxis Precision Medicines
PRAX
$8.8B
| $93K | ﹤0.01% |
+2,736
| New | +$136K |
|
3350
GoodRx Holdings
GDRX
$1.03B
| $91K | ﹤0.01% |
19,383
+2,153
| +12% | +$13.6K |
|
Similar funds
Dimensional Fund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Dimensional Fund Advisors held 3,606 positions worth $260B, down 6.6% from $279B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q3 2022 filing shows 143 new, 1,920 increased, 1,329 reduced and 119 closed positions. Its largest new stake was Yum China: 2,857,283 shares worth $135M. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $941M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q3 2022 buy was Yum China: 2,857,283 shares worth $135M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $332M increase.
- Dimensional Fund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $219M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q3 2022, selling an estimated $941M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $260B portfolio in Q3 2022.
- Dimensional Fund Advisors opened 143 new positions and closed 119 in Q3 2022.
- Dimensional Fund Advisors's portfolio value fell 6.6% quarter-over-quarter to $260B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.